How Cannabinoid Signaling Shapes Insulin Sensitivity in Humans
Cannabinoid receptor insulin sensitivity is explored in a controlled human trial using gold-standard metabolic clamp techniques. The findings show that CB1 receptor activity can shift insulin sensitivity without altering insulin secretion. This study…
Impact of Maternal Cannabis Exposure on Child Neurodevelopment
Maternal cannabis exposure and risk of ASD ADHD in offspring is a critical area of research. Studies show associations between peripregnancy cannabis use and behavioral outcomes in children. These findings highlight the importance of understanding…
Exploring the Endocannabinoid System in Mental Health Treatment Research
This article reviews recent endocannabinoid system mental health research focusing on its role in psychiatric disorders. Current studies explore how this system influences mental health treatment outcomes. Understanding these mechanisms may guide future…
Understanding Cannabis-Induced Psychosis and Psychiatric Progression
Cannabis-induced psychosis schizophrenia bipolar progression is a critical clinical concern. Patients with cannabis-induced psychosis have measurable risk for schizophrenia spectrum or bipolar disorder. Long-term monitoring is essential to identify those…
Digital Smoking Cessation Programs in HIV Care
Digital smoking cessation programs HIV provide tailored support for people living with HIV. These programs enable remote access to evidence-based cessation tools. Digital therapeutics show promising effectiveness in this underserved population.
Endocannabinoid System and Prenatal Cannabis: Clinical Research
Prenatal cannabis neurodevelopment risks include modestly increased chances of autism spectrum disorder and ADHD in offspring. Cannabis crosses the placenta and interacts with the endocannabinoid system during fetal brain development. Clinical research…
Exploring the Internalising Pathway of Cannabis Use in Teens
The internalising pathway cannabis use teens highlights how anxiety symptoms increase the risk of cannabis initiation and escalation. Adolescents with generalised anxiety are particularly vulnerable. Early intervention targeting these symptoms may reduce…
Endocannabinoid System in First-Episode Psychosis Care
People with first-episode psychosis have elevated rates of criminal legal involvement that are measurable at baseline and predictable using identifiable clinical and demographic factors. Early identification of individuals at higher risk for legal…
Endocannabinoid System in Trauma: Clinical Research Evidence
Clinical research highlights the role of the endocannabinoid system trauma substance use connection in posttraumatic outcomes. Insomnia symptoms before trauma predict higher rates of alcohol and cannabis use. Understanding this link aids early…
Daily Cannabis Use and Anxiety Relief: Outcomes by Product Type
Daily cannabis anxiety relief outcomes vary significantly by product type and cannabinoid composition. Research shows that flower and edible cannabis products produce different anxiety symptom changes over time. Understanding these outcomes helps guide…